In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EHJ – Cardiovascular Pharmacotherapy

Focusing on clinical cardiovascular pharmacology

 

The European Heart Journal — Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. It reports on the interpretation and integration of new scientific developments to improve the pharmacological treatment of patients with cardiovascular disease.

It publishes original articles on clinical research, including new and established drugs and methods, meta-analyses, and topical reviews. As of 1 January 2025, the journal will be open-access and available online only.

Submit your paper

Fast Facts

  • Editor-in-Chief: Stefan Agewall, FESC, NO
  • Current volume: 11 (2025)
  • Issues per subscription: 8
  • Impact Factor 2023: 5.4

Advertising, Reprints and Supplements

Oxford University Press (OUP) offers many services that help you reach ESC audiences or re-use the content published by the journals for educational purposes:

• Digital advertising puts your marketing message in front of ESC journal readers
• A peer-reviewed supplement communicates scientific research via a themed collection of papers
• ePrints are an ideal format for dissemination of published papers
• Licensing ESC content for excerpted local editions or CME ensures the best possible content for your region

Please contact OUP at jnlsadvertising@oup.com for further information.

Editor-in-Chief History

Name Start Date End Date
Prof. Stefan Agewall 01/01/2015  

 

Updates on latest articles

Updates on latest articles

 

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind, peer review by experienced international experts.